La Fleur & Godfrey LLC Novartis Ag Transaction History

La Fleur & Godfrey LLC

$723 Million
Q3 2024

A detailed history of La Fleur & Godfrey LLC transactions in Novartis Ag stock. As of the latest transaction made, La Fleur & Godfrey LLC holds 3,497 shares of NVS stock, worth $350,469. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,497

Previous 3,497 -0.0%

Holding current value

$350,469

Previous $372,000 8.06%

% of portfolio

0.06%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	BUY	$92.57 - $107.37 $55,449 - $64,314	599 Added 20.67%	3,497 $372,000
Q1 2024 Apr 23, 2024	SELL	$95.27 - $108.47 $57,066 - $64,973	-599 Reduced 17.13%	2,898 $280,000
Q4 2023 Jan 18, 2024	SELL	$92.27 - $101.54 $43,828 - $48,231	-475 Reduced 11.96%	3,497 $353,000
Q2 2023 Jul 20, 2023	SELL	$92.52 - $104.91 $64,764 - $73,437	-700 Reduced 14.98%	3,972 $400,000
Q1 2023 Apr 18, 2023	SELL	$80.03 - $92.81 $24,009 - $27,843	-300 Reduced 6.03%	4,672 $429,000
Q4 2022 Jan 12, 2023	BUY	$75.55 - $92.52 $45,254 - $55,419	599 Added 13.7%	4,972 $0
Q3 2022 Oct 17, 2022	SELL	$74.61 - $87.26 $158,620 - $185,514	-2,126 Reduced 32.71%	4,373 $332,000
Q1 2022 May 03, 2022	SELL	$80.11 - $90.62 $748,227 - $846,390	-9,340 Reduced 58.97%	6,499 $570,000
Q4 2021 Jan 26, 2022	SELL	$79.7 - $88.13 $41,444 - $45,827	-520 Reduced 3.18%	15,839 $1.39 Million
Q3 2021 Nov 01, 2021	BUY	$81.78 - $95.14 $39,090 - $45,476	478 Added 3.01%	16,359 $1.34 Million
Q2 2021 Jul 19, 2021	SELL	$85.24 - $94.15 $8,524 - $9,415	-100 Reduced 0.63%	15,881 $1.45 Million
Q1 2021 Apr 30, 2021	SELL	$83.5 - $98.47 $157,564 - $185,812	-1,887 Reduced 10.56%	15,981 $1.37 Million
Q4 2020 Jan 26, 2021	SELL	$78.07 - $94.43 $167,225 - $202,269	-2,142 Reduced 10.7%	17,868 $1.69 Million
Q3 2020 Nov 04, 2020	SELL	$82.14 - $91.0 $6.02 Million - $6.66 Million	-73,240 Reduced 78.54%	20,010 $1.74 Million
Q2 2020 Jul 28, 2020	SELL	$80.93 - $91.1 $468,099 - $526,922	-5,784 Reduced 5.84%	93,250 $8.14 Million
Q1 2020 May 04, 2020	BUY	$70.67 - $99.01 $1.98 Million - $2.77 Million	27,995 Added 39.41%	99,034 $8.17 Million
Q4 2019 Feb 04, 2020	BUY	$84.35 - $95.37 $355,282 - $401,698	4,212 Added 6.3%	71,039 $6.73 Million
Q3 2019 Oct 29, 2019	SELL	$85.54 - $94.26 $313,846 - $345,839	-3,669 Reduced 5.2%	66,827 $5.81 Million
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $194,532 - $239,424	2,580 Added 3.8%	70,496 $6.44 Million
Q1 2019 Apr 17, 2019	BUY	$75.32 - $86.15 $1.35 Million - $1.54 Million	17,880 Added 35.73%	67,916 $6.53 Million
Q4 2018 Feb 12, 2019	SELL	$73.66 - $82.02 $6,629 - $7,381	-90 Reduced 0.18%	50,036 $4.29 Million
Q3 2018 Dec 13, 2018	SELL	$66.94 - $77.43 $87,624 - $101,355	-1,309 Reduced 2.54%	50,126 $4.32 Million
Q2 2018 Dec 13, 2018	BUY	$64.91 - $73.36 $80,812 - $91,333	1,245 Added 2.48%	51,435 $3.89 Million
Q1 2018 Dec 13, 2018	BUY	$70.39 - $84.15 $244,112 - $291,832	3,468 Added 7.42%	50,190 $4.06 Million
Q4 2017 Jan 22, 2018	BUY	$72.33 - $77.64 $143,068 - $153,571	1,978 Added 4.42%	46,722 $3.92 Million
Q3 2017 Oct 26, 2017	BUY	$74.14 - $77.27 $3.32 Million - $3.46 Million	44,744	44,744 $3.84 Million

Others Institutions Holding NVS

# of Institutions

1,438

Shares Held

131M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $216B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of La Fleur & Godfrey LLC, based on Form 13F filings with the SEC.

News

Stay updated on La Fleur & Godfrey LLC with notifications on news.

Account

La Fleur & Godfrey LLC Novartis Ag Transaction History